ImageneBio/$IMA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ImageneBio
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
Ticker
$IMA
Sector
Primary listing
Employees
9
Headquarters
Website
ImageneBio Metrics
BasicAdvanced
$103M
-
-$0.09
-
-
Price and volume
Market cap
$103M
52-week high
$17.96
52-week low
$7.95
Average daily volume
35K
Financial strength
Current ratio
0.369
Quick ratio
0.179
Long term debt to equity
-0.821
Total debt to equity
-153.997
Interest coverage (TTM)
-68.79%
Profitability
EBITDA (TTM)
-21.435
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-503.65%
Operating margin (TTM)
-500.72%
Effective tax rate (TTM)
-0.06%
Revenue per employee (TTM)
$480,000
Management effectiveness
Valuation
Price to revenue (TTM)
838.045
Price to book
-21.33
Price to tangible book (TTM)
-21.33
Price to free cash flow (TTM)
-142.364
Free cash flow yield (TTM)
-0.70%
Free cash flow per share (TTM)
-0.065
Growth
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ImageneBio stock?
ImageneBio (IMA) has a market cap of $103M as of September 10, 2025.
What is the P/E ratio for ImageneBio stock?
The price to earnings (P/E) ratio for ImageneBio (IMA) stock is 0 as of September 10, 2025.
Does ImageneBio stock pay dividends?
No, ImageneBio (IMA) stock does not pay dividends to its shareholders as of September 10, 2025.
When is the next ImageneBio dividend payment date?
ImageneBio (IMA) stock does not pay dividends to its shareholders.
What is the beta indicator for ImageneBio?
ImageneBio (IMA) does not currently have a Beta indicator.